Peritoneal cancer is a complex and often misunderstood condition that affects the lining of the abdominal cavity. Traditionally, it was considered difficult to treat, but advances in surgical oncology have significantly improved outcomes. Today, specialized approaches like PIPAC cancer treatment and CRS HIPEC are offering new hope to patients.
As an experienced cancer surgeon in Mumbai, Dr. Ninad Katdare focuses on delivering cutting-edge care for patients diagnosed with peritoneal malignancies. These cancers often originate from or are associated with gastrointestinal cancer treatment pathways, including cancers of the stomach, colon, and appendix.
One of the most effective treatments available today is CRS HIPEC (Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy). This procedure involves surgically removing visible tumors from the abdomen, followed by the circulation of heated chemotherapy drugs directly inside the abdominal cavity. This targeted approach helps destroy microscopic cancer cells while minimizing systemic side effects.
Another innovative option is PIPAC cancer treatment (Pressurized Intraperitoneal Aerosol Chemotherapy). This minimally invasive technique delivers chemotherapy as a pressurized aerosol during laparoscopy, allowing for better penetration into tumor tissues. It is particularly useful for patients who may not be candidates for extensive surgery.
Peritoneal cancer is also closely linked to ovarian cancer treatment, as ovarian malignancies frequently spread to the peritoneal surfaces. In such cases, a multidisciplinary approach combining surgery and chemotherapy is crucial for achieving the best outcomes.
Choosing the right treatment requires expertise, precision, and individualized care. With advancements in technology and specialized techniques, patients now have access to more effective therapies than ever before. Early diagnosis and timely intervention remain key factors in improving survival rates.
